×

Pathway Genomics to Ring The Nasdaq Stock Market Closing Bell

ADVISORY, Jan. 05, 2016 (GLOBE NEWSWIRE) --

What:

Pathway Genomics Corporation, a global precision medical diagnostics company with mobile health applications designed to empower physicians and their patients to take control of their health and wellness, will visit the Nasdaq MarketSite in Times Square as part of Nasdaq’s 5th annual “Fit Week.” The week runs from January 4-8 and includes bell ceremonies featuring companies that help individuals lead healthier lifestyles.

In honor of the occasion, Jim Plante, Founder and CEO, will ring the Closing Bell.

For those seeking to get an extra edge on their New Year’s fitness goals, Pathway Genomics is offering its innovative PathwayFit® test for a special, limited-time price of $159 on Pathway’s mobile application or at https://www.pathway.com/pathway-fit/. PathwayFit is a physician-ordered saliva-based test that can uncover personal genetic predispositions to diet, exercise and other metabolic factors based on 75 different genetic markers. The test comes with information about each patient’s unique genetic profile, personalized meal plans and consultation with a licensed dietician.

Pathway Genomics has rapidly become a leader in the commercial healthcare industry and one of the fastest growing companies in the space. The company this week announced they have successfully raised over $40 million in Series E financing. This brings the total investment into Pathway Genomics to over $130 million.

In addition to ringing the Opening or Closing Bell during "Fit Week", participating companies will be featured on Nasdaq's Facebook, Twitter and Instagram pages where they will provide customized tips for maintaining a healthy lifestyle in 2016.

To find photos from Nasdaq "Fit Week" 2015 and for upcoming photos from "Fit Week" 2016, please visit: http://www.nasdaq.com/marketsite/fitweek1102/fitweek2016.html.

Where:

Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:

Wednesday, January 6, 2016 – 3:45 p.m. to 4:00 p.m. ET

Pathway Genomics Media Contact:
pr@pathway.com

Pathway Genomics Investor Relations:
Kamal Adawi – CFO
(858) 900-3002
Kamal.Adawi@Pathway.com

Nasdaq MarketSite:
Emily Pan
(646) 441-5120
emily.pan@nasdaq.com

Feed Information:

Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK

Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ.

For photos from ceremonies and events visit our Instagram Page: http://instagram.com/nasdaq.

For news tweets, please visit our Twitter page at: http://twitter.com/nasdaq.

For exciting viral content and ceremony photos visit Tumblr Page: http://nasdaq.tumblr.com/.

Webcast:

A webcast of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx.

Photos:

To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.

About Pathway Genomics Corporation

Since its founding in 2008, Pathway Genomics has rapidly become a leader in the commercial healthcare industry. Pathway Genomics’ success lies in its commitment to deliver innovative healthcare solutions. The company’s program with IBM Watson is the first of its kind. The program is a smartphone app that merges artificial intelligence and deep learning with personal genetic information. The app provides users with personalized health and wellness information based on the individual’s health history.

Based in San Diego, the company’s CLIA and CAP accredited clinical laboratory provides physicians and their patients in more than 40 different countries with actionable and accurate precision healthcare information to improve, or maintain, health and wellness. Pathway Genomics’ testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit www.pathway.com or follow us on Twitter, LinkedIn and Facebook.

About Nasdaq:

Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. NASDAQ is home to more than 3,500 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaq.com/ambition or www.nasdaqomx.com.

-NDAQA-

Source:NASDAQ, Inc.